| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 73,905 | 73,566 | 72,104 | 79,146 | | Cost of Revenue | (16,461) | 83,705 | 32,568 | 62,969 | | | Gross Profit | 90,366 | (10,139) | 39,536 | 16,177 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 82,574 | (19,097) | 31,109 | 6,286 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,962 | 3,631 | 3,607 | 3,526 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,830 | 5,327 | 4,820 | 6,365 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 48 | 78 | 90 | | Earnings Before Interest And Taxes | 3,815 | 5,375 | 4,898 | 6,455 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 3,815 | 5,375 | 4,898 | 6,455 | | Income Tax Expense | 1,346 | 1,967 | 1,845 | 2,435 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,469 | 3,408 | 3,053 | 4,020 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,469 | 3,408 | 3,053 | 4,020 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,469 | $3,408 | $3,053 | $4,020 |
|
0.20% Nasdaq 
Income Statement
